Remove Big Data Remove Clinical Trials Remove Genomics Remove Life Science
article thumbnail

Big data – charting a new path to drug discovery and development

Drug Discovery World

Tim Lowery , President, JSR Life Sciences, asks whether artificial intelligence can do for life sciences what it has done in other sectors and whether these tools can keep up with the complexities of human biology. So, where do we go from here to realise their potential in life sciences?

article thumbnail

How digital innovation is helping therapeutics to get to market faster

Drug Discovery World

As AI-designed drugs start to enter large-scale clinical trials, DDW’s Diana Spencer investigates how new digital tools are reinventing and reshaping drug discovery for the future. By making lab automation as easy as using a smartphone, the Flex robot democratises access to automation in life sciences research.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How big data analytics can make personalised care a reality

Drug Discovery World

Johannes Goll, Global Head of Emmes’ Biomedical Data Science and Bioinformatics department, explains how big data analytics can deliver improved therapies and bring clinical research one step close to realising the potential of personalised care.

article thumbnail

A history of AstraZeneca

pharmaphorum

Over 85,000 patients in 62 countries were evaluated in clinical trials of Nexium and close to 746 million patient treatments were administered by the end of 2007. TransCelerate BioPharma is the largest initiative of its kind and has end goals of improving the quality of clinical trials and bringing new medicines to patients faster.

article thumbnail

The challenges and trends of cell & gene therapies 

Drug Discovery World

And whilst clinical trials activity decreased by around 15% compared to 2020, last year still saw a number of regenerative medicines reach the bedside. As is always the case with pharmaceuticals, the industry’s capabilities to manufacture and produce these potentially life-saving therapies will be of concern. .

article thumbnail

The rise of real-world evidence: unlocking the potential in EHRs

pharmaphorum

Technologies such as Savana are helping companies augment clinical trials and take a deeper dive into information to extract insights that were previously inaccessible. There are a good number of use cases as to why pretty much every big life science company is choosing us these days,” says Medrano.

Doctors 116